PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
12-May-2023 ABBOTT ANNOUNCES NEW PARTNERSHIPS AND PROGRAMS TO ADVANCE ITS DIVERSITY IN CLINICAL TRIALS INITIATIVE Abbott
12-May-2023 England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably The Institute for Cancer Research, London
11-May-2023 The Karl Landsteiner University of Health Sciences Announces New England Journal of Medicine Shares Phase 3 Trial Data Evaluating Viaskin™ for Peanut-Allergic Toddlers Karl Landsteiner University of Health Sciences
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
10-May-2023 Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered Intravenously, in Non-Small Cell Lung Cancer Transgene
09-May-2023 ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting ImmunoGen
09-May-2023 Positive Interim Data of BellaSeno’s Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023 BellaSeno GmbH
08-May-2023 Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6 Omnix Medical
03-May-2023 CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor CluePoints
03-May-2023 AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs AARDEX Group
03-May-2023 ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Results Show Statistically Significant Improvements in PFS, ORR, and OS Compared to Chemotherapy First Medicine to Demonstrate an Overall Survival Advantage in Platinum-Resistant Ovarian Cancer Submission of MAA in Europe and sBLA in US Anticipated in H2 2023 ImmunoGen Inc.
02-May-2023 Lumea and OptraSCAN Announce Partnership to Enable Seamless Adoption of Digital Pathology OptraSCAN Inc
27-Apr-2023 ISA Pharmaceuticals to Present Pre-clinical Data on its Protective SLP Therapy Against SARS-CoV-2 at the CIMT Annual Meeting ISA Pharmaceuticals
26-Apr-2023 AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy AMO Pharma
25-Apr-2023 Greenphire Launches GreenSpace App and Expands Global Payment Functionality Greenphire
21-Apr-2023 B Corp Recruitment firm RBW Consulting launches findings from its second IMPACT initiative RBW Consulting
20-Apr-2023 Evaxion announces promising clinical data for DNA-based personalized cancer immunotherapy EVX-02: Phase 1/2a trial met both primary and secondary endpoints Evaxion
19-Apr-2023 Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality Veeva Systems
19-Apr-2023 Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck Oxford BioTherapeutics